ATE139702T1 - Die freisetzung des histamin hemmenden faktors sowie diesen enthaltende präparate - Google Patents

Die freisetzung des histamin hemmenden faktors sowie diesen enthaltende präparate

Info

Publication number
ATE139702T1
ATE139702T1 AT89901783T AT89901783T ATE139702T1 AT E139702 T1 ATE139702 T1 AT E139702T1 AT 89901783 T AT89901783 T AT 89901783T AT 89901783 T AT89901783 T AT 89901783T AT E139702 T1 ATE139702 T1 AT E139702T1
Authority
AT
Austria
Prior art keywords
hrif
treatment
methods
cell lines
release
Prior art date
Application number
AT89901783T
Other languages
English (en)
Inventor
Rafeul Alam
J Andrew Grant
Michael A Lett-Brown
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas filed Critical Univ Texas
Application granted granted Critical
Publication of ATE139702T1 publication Critical patent/ATE139702T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0642—Granulocytes, e.g. basopils, eosinophils, neutrophils, mast cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT89901783T 1988-01-12 1989-01-11 Die freisetzung des histamin hemmenden faktors sowie diesen enthaltende präparate ATE139702T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14309488A 1988-01-12 1988-01-12

Publications (1)

Publication Number Publication Date
ATE139702T1 true ATE139702T1 (de) 1996-07-15

Family

ID=22502579

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89901783T ATE139702T1 (de) 1988-01-12 1989-01-11 Die freisetzung des histamin hemmenden faktors sowie diesen enthaltende präparate

Country Status (6)

Country Link
EP (1) EP0398924B1 (de)
AT (1) ATE139702T1 (de)
AU (1) AU2947889A (de)
CA (1) CA1334652C (de)
DE (1) DE68926743T2 (de)
WO (1) WO1989006545A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06502396A (ja) * 1990-07-25 1994-03-17 ボード、オブ、リージェンツ、ザ、ユニバーシティー、オブ、テキサス、システム 好塩基球からのサイトカイン誘導ヒスタミン放出のインターロイキン８阻害
ES2249863T3 (es) * 1995-02-27 2006-04-01 Gilead Sciences, Inc. Inhibidores selectivos de neuraminidasa viral o bacteriana.
CN112899228B (zh) * 2021-02-04 2022-09-23 广州医科大学附属第一医院 一种从支气管肺泡灌洗液中分离提取细胞的方法

Also Published As

Publication number Publication date
EP0398924A1 (de) 1990-11-28
CA1334652C (en) 1995-03-07
WO1989006545A1 (en) 1989-07-27
DE68926743T2 (de) 1997-01-09
DE68926743D1 (de) 1996-08-01
EP0398924B1 (de) 1996-06-26
AU2947889A (en) 1989-08-11

Similar Documents

Publication Publication Date Title
ATE180255T1 (de) Guanidinderivate mit therapeutischer wirkung
DK1020179T3 (da) Peptidderivater eller farmaceutisk acceptable salte deraf, fremgangsmåde til fremstilling af de samme, anvendelse af derivaterne og farmaceutisk sammensætning
HUP9902698A2 (hu) Humán bikunin
KR950700333A (ko) 개량된 알파 인터페론 조성물 및 인간 말초혈 백혈구로부터의 제조 방법(improved alpha interferon composition and method for its production from human peripheral blood leukocytes)
EA200000723A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
DK0559632T3 (da) Fremgangsmåde til fremstilling af vævsfaktorreaktionsvejsinhibitor
MY130035A (en) Antiviral compounds
EP0249736A3 (de) Salbe zur Behandlung von Hauterkrankungen
DK0396184T3 (da) Anvendelse af ketoconazol og et retinoid til behandling af acne vulgaris
IT1263013B (it) Esteri della l-carnitina e di alcanoil l-carnitine con l'acido glicolico o suoi esteri e composizioni farmaceutiche contenenti tali per il trattamento di affezioni cutanee.
ZA898605B (en) Compositions for topical treatment of skin diseases
KR900700495A (ko) 치료제로서 유용한 치환된 아데닌 유도체
NO172043C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-2,3-butadienyl-triamioalkanderivater
ATE174798T1 (de) Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation
ATE139702T1 (de) Die freisetzung des histamin hemmenden faktors sowie diesen enthaltende präparate
DK0700897T3 (da) L-carnitinsalt og kosmetiske og farmaceutiske præparater indeholdende samme til behandling af hudsygdomme
IT8721115A0 (it) Fitopreparato per la cura di affezioni cutanee.
NO970573D0 (no) Ylidenforbindelser og deres fremstilling
IT9020968A0 (it) Metodi e composizioni farmaceutiche per il trattamento di malattie oftalmiche
IE870577L (en) Topical amide preparation
DK0505400T3 (da) N-substituerede naphthalimider, deres fremstilling og anvendelse
NO923198L (no) Terapeutiske midler
NO891071L (no) Fremgangsmaate for fremstilling av 4,5,6,7-tetrahydro-isotiazolo(4,5-c)-pyridinderivater og isomere.
YU60199A (sh) Nove soli bpc peptida sa organo-zaštitnom aktivnošću, postupak za njihovo dobijanje i njihova primena u terapiji
SE8200748L (sv) Terapeutiskt medel

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties